Themis Medicare Limited has informed the Exchange regarding a press release dated November 10, 2023, titled " Themis Medicare Launches REMITHEM�� REMIFENTANIL Injection A Novel Narcotic Analgesic for use during induction of anesthesia, during immediate post-operative period and in monitored anesthesia care .".
Press Release Nov 10 2023
Earlier from Themis Medicare
- Press Release Feb 17 2023
- Press Release Jan 03 2023
- Press Release Nov 08 2022
- Press Release Oct 06 2022